1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6468E4275D6441E68852580430051D069
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-pharma-new-product-planning-excellence-medical-affairs-brand-strategy-timing-activities?opendocument
18
19opendocument
2034.229.24.100
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services New Product Development New Product Planning

Pharmaceutical New Product Planning Excellence: Medical Affairs, Brand Strategy and Timing of Activities

ID: 5437


Features:

18 Info Graphics

22 Data Graphics

200+ Metrics

2 Narratives


Pages/Slides: 49


Published: 2016


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from "Pharmaceutical New Product Planning Excellence: Medical Affairs, Brand Strategy and Timing of Activities"

STUDY OVERVIEW

The pharmaceutical industry's New Product Planning (NPP) function has become the central conduit for assessing potential therapies as they progress through the three stages of drug development. NPP engages in a series of activities designed to determine the market fit and potential profitability of identified candidates and to prepare for key commercial activities, such as positioning and branding. Two of the critical areas that the NPP function assess are medical affairs and brand strategy.


Best Practices, LLC undertook this benchmarking study to determine which medical affairs and brand activities should be conducted and when for the NPP group. The study identifies the timing of key medical affairs and brand strategy NPP activities in launch & pre-launch. The research also includes chapters on the current state of NPP in the pharma sector and key patterns in the timing of NPP activities.


KEY TOPICS

  • The State of New Product Planning
  • New Product Planning Activities: Key Patterns And Activities
  • New Product Planning Activities: Medical Affairs
  • New Product Planning Activities: Brand Strategy


KEY METRICS
  • Timing of Medical Affairs Activities
  • Timing of Publication Strategy & Planning
  • Timing of Branding of the Science
  • Timing of Medical Meeting Plan
  • Timing of Thought Leader Management (HCP/Payer)
  • Timing of Thought Leader Identification (HCP/Payer)
  • Timing of Advisory Boards
  • Timing of Advocacy Groups ID/ Management
  • Timing of Brand Strategy Activities
  • Timing of Positioning
  • Timing of Development of Brand
  • Timing of Generic Naming
  • Timing of Trade Naming
  • Timing of Trade Packaging/Formulations

SAMPLE KEY FINDINGS
  • Branding Activities for Global & Regional Teams Start in Phase II and Phase III Respectively: More than 67% of global teams start trade packaging, generic naming and positioning in phase II, while close to 88% of global companies start brand development and trade naming in phase III. More than 75% of regional teams start all but generic naming in phase III.

METHODOLOGY

For this research project, Best Practices, LLC engaged 19 leaders from 15 leading pharmaceutical, biotech, and life sciences companies.

Industries Profiled:
Biopharmaceutical; Pharmaceutical; Medical Device; Biotech; Health Care; Clinical Research; Laboratories; Manufacturing; Consumer Products; Diagnostic


Companies Profiled:
Alkermes; Zydus Cadila; GlaxoSmithKline ; Astellas; Roche; Novartis; Sanofi; Pfizer; Takeda Pharmaceuticals; Cytokinetics; Allergan; Medicago; Bayer; Galderma; Wockhardt

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.